Impact

September 4, 2024

After several months and as many email exchanges, an erratum to Arsh et al. (2024) has been published.1,2 See the relevant page for details.

gantt
  dateFormat YYYY-MM-DD
  axisFormat %b %Y
  todayMarker off

  Article published : milestone,2024-01-03,2024-01-03
  AcAI contacts journal : milestone,2024-03-19,2024-03-19
  Editor-in-Chief response—will investigate : milestone,2024-03-20,2024-03-20
  Update—authors confirm use of AI tools, erratum to be published : milestone,2024-03-21,2024-03-21
  AcAI request for update : milestone,2024-04-30,2024-04-30
Response—erratum being prepared for next available issue : milestone,2024-04-30
  AcAI request for update : milestone,2024-08-12
Response—erratum being prepared for next available issue : milestone,2024-08-13
Erratum published : milestone,2024-09-04

Timeline of correspondence between Academ-AI and the journal.

August 27, 2024

Academ-AI is honored to be recommended by Retraction Watch on their Papers and peer reviews with evidence of ChatGPT writing page.

May 2, 2024

An article3 by Bader et al., originally published on March 8, 2024, was finally removed from Radiology Case Reports after more than a month of discussion in newspapers, blogs, and social media, as well as my own correspondence with the journals’ editors. See the relevant page for details.

Timeline of discussion concerning the article by Bader et al.

April 21, 2024

In my article “The case for universal artificial intelligence declaration on the precedent of conflict of interest,” published today, I argue that journals should require authors to declare that they have or have not used generative AI for each and every submission.4 I contend that authors will be less inclined to actively deceive journals concerning their use of generative AI than some have been to passively omit any declaration.

April 3, 2024

Today, my article “Suspected undeclared use of generative artificial intelligence” was published in Intelligent Pharmacy.5 The journal previously published an article by Verma et al., in which the telltale phrase “as of my last update” appeared.6 I addressed this article as well as explaining the significance of the undeclared AI problem.

References

1Arsh H, Manoj Kumar FNU, Simran FNU, et al. Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review. Annals of Medicine and Surgery. 2024;86(2):899-908. doi:10.1097/MS9.0000000000001601
2Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review: Erratum. Annals of Medicine and Surgery. 2024;86(9):5659. doi:10.1097/MS9.0000000000002497
3Bader R, Imam A, Alnees M, et al. Successful management of an Iatrogenic portal vein and hepatic artery injury in a 4-month-old female patient: A case report and literature review. Radiology Case Reports. 2024;19(6):2106-2111. doi:10.1016/j.radcr.2024.02.037
4Glynn A. The case for universal artificial intelligence declaration on the precedent of conflict of interest. Accountability in Research. Published online 2024. doi:10.1080/08989621.2024.2345719
5Glynn A. Suspected undeclared use of generative artificial intelligence. Intelligent Pharmacy. Published online April 3, 2024. doi:10.1016/j.ipha.2024.03.003
6Verma S, Tiwari RK, Singh L. Integrating technology and trust: Trailblazing role of AI in reframing pharmaceutical digital outreach. Intelligent Pharmacy. Published online January 15, 2024. doi:10.1016/j.ipha.2024.01.005